Rekrutierung

Eingeschlossene Patienten: 20.371 (Stand 1. April 2021) 
Amgevita® (Adalimumab)110
Benepali® (Etanercept)775
Cimzia® (Certolizumab)949
Enbrel® (Etanercept)2866
Erelzi® (Etanercept)341
Flixabi® (Infliximab)9
Hulio® (Adalimumab)67
Humira® (Adalimumab)2903
Hyrimoz® (Adalimumab)87
Idacio® (Adalimumab)25
Imraldi® (Adalimumab)112
Inflectra™ (Infliximab)16
Jyseleca® (Filgotinib)10
Kevzara® (Sarilumab)156
Kineret® (Anakinra)89
MabThera® (Rituximab)1458
Nepexto® (Etanercept)11
Olumiant® (Baricitinib)437
Orencia® (Abatacept)865
Remicade® (Infliximab)762
Remsima® (Infliximab)11
Rinvoq® (Upadacitinib)139
Rixathon® (Rituximab)16
RoActemra® (Tocilizumab)1331
Ruxience® (Rituximab)1
Simponi® (Golimumab)447
Xeljanz® (Tofacitinib)350
Zessly® (Infliximab)2
Kontrollen6026